(EMAILWIRE.COM, September 13, 2019 ) Market Overview:
The Anti Hypertension Therapeutics Market is estimated to decline at a CAGR of XX% during 2019-2026 and grow after that. Patent expiry of the major drugs is the primary reason for the decline in the market during 2019-2026 while new launches are forecasted to increase the demand from 2019-2026.
High penetration of fixed dosage drugs, rise in prevalence of the global population suffering
Patent expiry of major drugs, the adverse impact of drugs, the presence of a considerable number of substitutes, and poor patient compliance are the significant factors challenging the growth of the market in the forecasted period.
Segmentation by Therapy Type
Calcium Channel Blockers
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Angiotensin Receptor Blockers
Endothelin receptor antagonist
Segmentation by Drug Class
Pulmonary Arterial Hypertension
By Geography, the market is segmented into:
The Middle East and Africa
View full report: http://www.datamintelligence.com/research-report/anti-hypertension-drugs-market
Download free sample: http://www.datamintelligence.com/download-sample/adaptive-robotics-market
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sales Manager at Data M Intelligence
Tel: +1 877 441 4866
+1 877 441 4866
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
News Provided by EmailWire